A Study to Investigate HCV Response Rates in Real World Patients: HEARTLAND Study
Status:
Completed
Trial end date:
2017-09-01
Target enrollment:
Participant gender:
Summary
This is a Phase IV, open label, single center study of OBV/PTV/r + DSV +/- RBV for 12 or 24
weeks for the treatment of chronic HCV-1 infection in a real world urban clinical setting.